In addition to Mr. O’Neill, candidates whose names have recently surfaced include Dr. Scott Gottlieb, a former F.D.A. official with longstanding ties to pharmaceutical and biotech companies, and Dr. Joseph Gulfo, a former biotech and medical device executive. “Let people start using them, at their own risk,” Mr. O’Neill said. Mr. O’Neill did not respond to emails and a phone call requesting comment, and Dr. Gottlieb declined to comment. “The only way you would make it shorter is you staff up,” said Michael Gilman, an entrepreneur who has founded several biotech companies.

Source: New York Times February 05, 2017 17:13 UTC